Moore Capital Management, LP Ultragenyx Pharmaceutical Inc. Transaction History
Moore Capital Management, LP
- $4.06 Billion
- Q1 2025
A detailed history of Moore Capital Management, LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Moore Capital Management, LP holds 240,000 shares of RARE stock, worth $8.91 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
240,000
Previous 245,000
2.04%
Holding current value
$8.91 Million
Previous $10.3 Million
15.69%
% of portfolio
0.21%
Previous 0.13%
Shares
6 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
88.9MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$371 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$208 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$155 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$119 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$97.2 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.6B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...